There have been 50 recent insider transactions recorded for Iovance Biotherapeutics, Inc. (IOVA), including 20 buys and 28 sells. Total insider buying was valued at $107.19K and total insider selling at $50.63K.
Notable insiders with recent activity include Bilinsky Igor, Vogt Frederick G, Graf Finckenstein Friedrich. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — IOVA
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-09 |
Bilinsky Igor |
Chief Operating Officer |
RSU Award |
117,500 |
- |
- |
117,500 |
| 2026-03-09 |
Vogt Frederick G |
Interim CEO & General Counsel |
RSU Award |
235,000 |
- |
- |
235,000 |
| 2026-03-09 |
Graf Finckenstein Friedrich |
Chief Medical Officer |
RSU Award |
58,750 |
- |
- |
58,750 |
| 2026-03-09 |
Roche Corleen M. |
Chief Financial Officer |
RSU Award |
132,200 |
- |
- |
132,200 |
| 2026-03-09 |
Puri Raj K. |
Chief Regulatory Officer |
RSU Award |
117,500 |
- |
- |
117,500 |
| 2026-03-09 |
Kirby Daniel Gordon |
Chief Commercial Officer |
RSU Award |
132,200 |
- |
- |
132,200 |
| 2026-03-05 |
Bilinsky Igor |
Chief Operating Officer |
Option Exercise (Sell) |
31,246 |
- |
- |
62,504 |
| 2026-03-05 |
Vogt Frederick G |
Interim CEO & General Counsel |
Option Exercise (Sell) |
62,493 |
- |
- |
125,007 |
| 2026-03-05 |
Graf Finckenstein Friedrich |
Chief Medical Officer |
Option Exercise (Sell) |
31,246 |
- |
- |
62,504 |
| 2026-03-05 |
Puri Raj K. |
Chief Regulatory Officer |
Option Exercise (Sell) |
39,059 |
- |
- |
78,131 |
| 2026-03-02 |
Bilinsky Igor |
Chief Operating Officer |
Option Exercise (Sell) |
3,517 |
- |
- |
- |
| 2026-03-02 |
Vogt Frederick G |
Interim CEO & General Counsel |
Option Exercise (Sell) |
10,418 |
- |
- |
- |
| 2026-03-02 |
Graf Finckenstein Friedrich |
Chief Medical Officer |
Option Exercise (Sell) |
3,907 |
- |
- |
- |
| 2026-03-02 |
Puri Raj K. |
Chief Regulatory Officer |
Option Exercise (Sell) |
5,470 |
- |
- |
21,878 |
| 2026-02-24 |
Kirby Daniel Gordon |
Chief Commercial Officer |
Option Exercise (Sell) |
150,000 |
- |
- |
- |
| 2026-02-10 |
Kirby Daniel Gordon |
Chief Commercial Officer |
Tax Withholding of RSU |
16,450 |
$2.60 |
$42.77K |
53,546 |
| 2025-12-02 |
Bilinsky Igor |
Chief Operating Officer |
Option Exercise (Sell) |
3,516 |
- |
- |
3,517 |
| 2025-12-02 |
Vogt Frederick G |
Interim CEO & General Counsel |
Option Exercise (Sell) |
10,417 |
- |
- |
10,418 |
| 2025-12-02 |
Graf Finckenstein Friedrich |
Chief Medical Officer |
Option Exercise (Sell) |
3,906 |
- |
- |
3,907 |
| 2025-12-01 |
Bilinsky Igor |
Chief Operating Officer |
Option Exercise (Sell) |
8,789 |
- |
- |
43,949 |
| 2025-12-01 |
Vogt Frederick G |
Interim CEO & General Counsel |
Option Exercise (Sell) |
41,669 |
- |
- |
208,344 |
| 2025-12-01 |
Graf Finckenstein Friedrich |
Chief Medical Officer |
Option Exercise (Sell) |
8,789 |
- |
- |
43,949 |
| 2025-12-01 |
Puri Raj K. |
Chief Regulatory Officer |
Option Exercise (Sell) |
5,469 |
- |
- |
27,348 |
| 2025-09-02 |
Bilinsky Igor |
Chief Operating Officer |
Option Exercise (Sell) |
3,516 |
- |
- |
7,033 |
| 2025-09-02 |
Vogt Frederick G |
Interim CEO & General Counsel |
Option Exercise (Sell) |
10,417 |
- |
- |
20,385 |
| 2025-09-02 |
Graf Finckenstein Friedrich |
Chief Medical Officer |
Option Exercise (Sell) |
3,907 |
- |
- |
7,813 |
| 2025-09-02 |
Puri Raj K. |
Chief Regulatory Officer |
Option Exercise (Sell) |
5,470 |
- |
- |
32,817 |
| 2025-08-06 |
Roche Corleen M. |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-08-06 |
Roche Corleen M. |
Chief Financial Officer |
RSU Award |
150,000 |
- |
- |
150,000 |
| 2025-06-30 |
Rosinack Matthew W. |
SVP, Finance (int. Pfo & Pao) |
Unknown |
75,000 |
$25.30 |
$1.9M |
- |
| 2025-06-13 |
Yarno Wendy L |
Director |
RSU Award |
67,546 |
- |
- |
67,546 |
| 2025-06-13 |
Weiser Michael |
Director |
RSU Award |
67,546 |
- |
- |
67,546 |
| 2025-06-13 |
Maynard Ryan D |
Director |
RSU Award |
67,546 |
- |
- |
67,546 |
| 2025-06-13 |
Countouriotis Athena |
Director |
RSU Award |
67,546 |
- |
- |
67,546 |
| 2025-06-13 |
Dukes Iain D. |
Director |
RSU Award |
135,092 |
- |
- |
135,092 |
| 2025-06-05 |
Kirby Daniel Gordon |
Chief Commercial Officer |
Informative Buy |
30,000 |
$1.84 |
$55.2K |
30,000 |
| 2025-06-02 |
Bilinsky Igor |
Chief Operating Officer |
Option Exercise (Sell) |
3,516 |
- |
- |
10,549 |
| 2025-06-02 |
Vogt Frederick G |
Interim CEO & General Counsel |
Option Exercise (Sell) |
10,417 |
- |
- |
31,252 |
| 2025-06-02 |
Bellemin Jean-marc |
Chief Financial Officer |
Tax Withholding of RSU |
4,464 |
$1.76 |
$7.86K |
60,529 |
| 2025-06-02 |
Graf Finckenstein Friedrich |
Chief Medical Officer |
Option Exercise (Sell) |
3,906 |
- |
- |
11,720 |
| 2025-06-02 |
Puri Raj K. |
Chief Regulatory Officer |
Option Exercise (Sell) |
5,469 |
- |
- |
38,287 |
| 2025-05-23 |
Puri Raj K. |
Chief Regulatory Officer |
Informative Buy |
5,600 |
$1.74 |
$9.74K |
206,852 |
| 2025-05-14 |
Vogt Frederick G |
Interim CEO & General Counsel |
Informative Buy |
25,000 |
$1.69 |
$42.25K |
374,646 |
| 2025-03-14 |
Puri Raj K. |
Chief Regulatory Officer |
Option Exercise (Sell) |
8,334 |
- |
- |
- |
| 2025-03-05 |
Bilinsky Igor |
Chief Operating Officer |
RSU Award |
93,750 |
- |
- |
93,750 |
| 2025-03-05 |
Vogt Frederick G |
Interim CEO & General Counsel |
RSU Award |
187,500 |
- |
- |
187,500 |
| 2025-03-05 |
Bellemin Jean-marc |
Chief Financial Officer |
RSU Award |
93,750 |
- |
- |
93,750 |
| 2025-03-05 |
Graf Finckenstein Friedrich |
Chief Medical Officer |
RSU Award |
93,750 |
- |
- |
93,750 |
| 2025-03-05 |
Puri Raj K. |
Chief Regulatory Officer |
RSU Award |
117,190 |
- |
- |
117,190 |
| 2025-03-03 |
Bilinsky Igor |
Chief Operating Officer |
Option Exercise (Sell) |
3,516 |
- |
- |
14,065 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
